News
How the secrets of the ‘water bear’ could improve lifesaving drugs like insulin
Originally published on UCLA Newsroom https://newsroom.ucla.edu/stories/water-bear-secret-to-improving-lifesaving-medications
How the secrets of the ‘water bear’ could improve lifesaving drugs like insulin
Inspired by creatures that survive in harsh environments and aided by UCLA’s Innovation Fund, a team has invented a polymer with the potential to extend the shelf life and reach of medications
UCLA TDG Innovation Magazine Summer 2022
UCLA TDG Innovation Magazine Summer 2022
In this issue
- Recaps of the MedTech and LABEST 2022 Conferences - in person!
- Fighting Brain Fog
- Tackling a Concrete Jungle
LABEST 2022 VIDEOS now on YouTube
LABEST 2022 Main Track and Professor Spotlights are now viewable on YouTube
Make sure to subscribe when you get there!
LATEST UPDATE: LABEST 2022 is SOLD OUT!
LATEST UPDATE: LABEST 2022 is SOLD OUT !!!
A LImited Number of Walk Up tickets may be available the day of the event starting at 5/26 at 8AM but not guaranteed.
View Full Online Program, Poster Entries and Professor Spotlights Here.
Talking Tech Transfer: Amir Naiberg
Amir Naiberg has been the associate vice-chancellor and CEO and president of UCLA Technology Development Group since 2016, when he joined from having led Yeda, the tech transfer arm of Weizmann Institute of Science.
In Memoriam - Brian Roe
In memoriam: Brian Roe, 41, director at UCLA Technology Development Group
Marivi Valcourt | April 5, 2022
Brian Roe, director of the industry research and material transfer team at the UCLA Technology Development Group, died March 23. He was 41.
24 scientists and researchers receive awards from UCLA TDG
24 scientists and researchers receive awards from Technology Development Group
Marivi Valcourt | April 4, 2022
Twenty-four researchers at UCLA have been named recipients of awards from the 2021 UCLA Innovation Fund Biomedical Competition.
Potential glioblastoma treatment has roots in UCLA graduate research
Potential glioblastoma treatment has roots in UCLA graduate research
Recently approved for clinical trials, ERAS-801 was developed by a trio of faculty members
Marivi Valcourt | March 15, 2022
A potential new treatment for glioblastoma that recently received approval for clinical trials not only was developed by three UCLA faculty members but also traces its roots back to 2005, when one of the researchers was a UCLA graduate student.